New PET tracer could sharpen detection of hard-to-see lymphomas
NCT ID NCT02128945
First seen Apr 09, 2026 · Last updated May 10, 2026 · Updated 1 time
Summary
This early-phase study tested a new radioactive tracer, [18F]-Fludarabine, in 10 adults with untreated chronic lymphocytic leukemia or diffuse large B-cell lymphoma. The goal was to see how the tracer spreads in the body and how well it highlights cancer cells compared to standard PET scans. The approach aims to improve diagnosis and treatment monitoring for these lymphoid cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital
Caen, 14000, France
Conditions
Explore the condition pages connected to this study.